Skip to main content
Signal8
Thompson Travis Alvin profile photo

Travis Alvin Thompson

CIK: 0001983944

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)24 (77.4%)

Position reduction

Option Exercises (M)3 (9.7%)

Derivative conversions

Awards (A)4 (12.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BICYCLE THERAPEUTICS PLC logo
BCYC

BICYCLE THERAPEUTICS PLC

Officer

Discretionary Trading P&L

Holdings

Transaction History (31 total)

  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Oct 5, 2026
    Sale(S)
    Direct
    79 shares at avg. $3.57$282.03
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Oct 2, 2026
    Sale(S)
    Direct
    893 shares at avg. $3.47$3K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jul 15, 2026
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    60K shares-
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jul 6, 2026
    Sale(S)
    Direct
    104 shares at avg. $4.31$448.24
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jul 2, 2026
    Sale(S)
    Direct
    819 shares at avg. $4.27$3K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Apr 6, 2026
    Sale(S)
    Direct
    102 shares at avg. $5.05$515.1
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Apr 2, 2026
    Sale(S)
    Direct
    799 shares at avg. $4.91$4K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Feb 3, 2026
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    58K shares-
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jan 5, 2026
    Sale(S)
    Direct
    1.1K shares at avg. $6.45$7K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jan 2, 2026
    Award(A)
    Direct
    37.5K shares-
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jan 2, 2026
    Sale(S)
    Direct
    1.3K shares at avg. $6.80$9K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Oct 3, 2025
    Sale(S)
    Direct
    103 shares at avg. $8.41$866.23
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Oct 2, 2025
    Sale(S)
    Direct
    221 shares at avg. $8.40$2K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jul 3, 2025
    Sale(S)
    Direct
    100 shares at avg. $7.44$744
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jul 2, 2025
    Sale(S)
    Direct
    206 shares at avg. $7.09$1K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Apr 3, 2025
    Sale(S)
    Direct
    109 shares at avg. $7.48$815.32
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Apr 2, 2025
    Sale(S)
    Direct
    210 shares at avg. $8.02$2K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jan 6, 2025
    Sale(S)
    Direct
    2.7K shares at avg. $15.00$40K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jan 3, 2025
    Sale(S)
    Direct
    159 shares at avg. $14.75$2K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jan 2, 2025
    Award(A)
    Direct
    17.5K shares-
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Jan 2, 2025
    Sale(S)
    Direct
    1.8K shares at avg. $14.09$25K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Nov 11, 2024
    Sale(S)
    Direct
    1.1K shares at avg. $25.05$28K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Nov 11, 2024
    Sale(S)
    Direct
    3.2K shares at avg. $25.21$82K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Nov 11, 2024
    Exercise(M)
    Direct
    1.3K shares at avg. $1.87$2K
  • BICYCLE THERAPEUTICS PLC logo
    BCYC

    BICYCLE THERAPEUTICS PLC

    Nov 11, 2024
    Sale(S)
    Direct
    231 shares at avg. $24.82$6K

1-25 of 31

About Thompson Travis Alvin

Thompson Travis Alvin (SEC CIK 0001983944) files insider reports with the SEC as Chief Financial Officer of BICYCLE THERAPEUTICS PLC (BCYC).

Signal8 holds 13 ownership filings by Thompson Travis Alvin (1 Form 3, 12 Form 4), filed between Oct 4, 2024 and Oct 6, 2026. Those filings report 31 transactions, from Oct 3, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Thompson Travis Alvin's filings is in CAMBRIDGE.

Recent filings by Thompson Travis Alvin

  • Oct 5, 2026: Open-market sale of BCYC shares (Form 4, code S).
  • Oct 2, 2026: Open-market sale of BCYC shares (Form 4, code S).
  • Jul 15, 2026: Grant or award of BCYC derivative securities (Form 4, code A).
  • Jul 6, 2026: Open-market sale of BCYC shares (Form 4, code S).
  • Jul 2, 2026: Open-market sale of BCYC shares (Form 4, code S).

Other insiders filing for BICYCLE THERAPEUTICS PLC (BCYC)

How to read Form 4 transaction codes